body > *:not(noscript) { display: none !important; } noscript { display: block !important; } .no-js-warning { display: flex !important; min-height: 100vh; align-items: center; justify-content: center; padding: 20px; background: #f8f9fa; text-align: center; } .no-js-card { max-width: 500px; padding: 30px; border-radius: 12px; background: white; box-shadow: 0 10px 30px rgba(0,0,0,0.08); font-family: Arial, sans-serif; } .no-js-card h1 { margin-bottom: 10px; }

JavaScript Required

JavaScript is required for this website to work correctly and provide a smooth user experience. Please enable JavaScript in your browser, then refresh the page.

Back to PharmaIndex

Lipaglyn Tablet

Saroglitazar (4mg)

Train on this drug

Drug details

API

Saroglitazar (4mg)

Drug classification

Dosage form

API strength per dosage

Dose

Mechanism of action

Indications

Treatment of Noncirrhotic Non-Alcoholic SteatohepatitisTreatment of Non-alcoholic fatty liver diseaseTreatment of Diabetic dyslipidemia (high cholesterol in diabetes)

Side effects

Flatulence Indigestion Abdominal distension Weakness Increased body temperature

Pregnancy category

Precautions

Contraindications

Interaction checker

Check interactions

Ask about possible interactions, counseling points, and safety considerations for this medicine.

Drug interaction assistant

Ask about Lipaglyn Tablet with another medicine, food, condition, or counseling concern.

PharmaProLearn

Excel Beyond Limits